03/11/2024 3:37 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/08/2024 3:50 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 5:38 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/26/2024 3:35 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) KalVista Pharmaceuticals (Subject)
| Form SC 13G | |
02/22/2024 12:22 PM | Frazier Life Sciences Public Fund, L.P. (Filed by) KalVista Pharmaceuticals (Subject)
| Form SC 13D/A | |
02/21/2024 8:51 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:41 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
02/21/2024 8:44 PM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:46 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:48 PM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 3:49 PM | KalVista Pharmaceuticals (Subject) TCG Crossover GP I, LLC (Filed by)
| Form SC 13D/A | |
02/16/2024 3:32 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 3:20 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:21 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:52 PM | KalVista Pharmaceuticals (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024 4:13 PM | KalVista Pharmaceuticals (Filer)
| Form 424B5 | |
02/13/2024 8:11 AM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 8:20 AM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 8:23 AM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 8:06 AM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 8:08 AM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:55 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 7:30 PM | KalVista Pharmaceuticals (Subject) Saturn V Capital Management LP (Filed by)
| Form SC 13G | |
02/09/2024 8:16 AM | KalVista Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024 7:11 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 3:38 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 6:07 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 7:24 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:02 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 6:04 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 3:26 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 7:57 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 5:05 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:24 PM | KalVista Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/08/2024 3:47 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 3:13 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 5:44 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 3:16 PM | KalVista Pharmaceuticals (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
12/27/2023 4:12 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 12:33 PM | Frazier Life Sciences Public Fund, L.P. (Filed by) KalVista Pharmaceuticals (Subject)
| Form SC 13D/A | |
09/28/2023 3:52 PM | Cha Albert (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
09/28/2023 3:53 PM | KalVista Pharmaceuticals (Issuer) Pereira Brian JG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/28/2023 3:54 PM | KalVista Pharmaceuticals (Issuer) Unkart Edward W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/28/2023 3:54 PM | KalVista Pharmaceuticals (Issuer) Stuart Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/28/2023 3:55 PM | KalVista Pharmaceuticals (Issuer) Treanor Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2023 3:29 PM | Cha Albert (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 5:05 PM | Cha Albert (Reporting) KalVista Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 3:35 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 3:18 PM | KalVista Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/21/2023 7:05 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:05 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:06 PM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:07 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:09 PM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 3:30 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2023 8:37 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4/A | |
05/22/2023 8:39 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4/A | |
05/22/2023 8:40 PM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4/A | |
05/22/2023 8:33 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2023 8:35 PM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4/A | |
05/22/2023 8:36 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4/A | |
05/19/2023 8:18 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 8:19 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 8:20 PM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 8:16 PM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 8:17 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |